{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T20:44:07Z","timestamp":1692477847552},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T00:00:00Z","timestamp":1417996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T00:00:00Z","timestamp":1417996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1038\/bmt.2014.272","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T18:37:49Z","timestamp":1418063869000},"page":"455-456","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Myeloablative BU, fludarabine, antithymocyte globulin and low-dose TBI in the treatment of juvenile myelomonocytic leukaemia with allogeneic haematopoietic cell transplantation"],"prefix":"10.1038","volume":"50","author":[{"given":"G M T","family":"Guilcher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Moorjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T H","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V A","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,8]]},"reference":[{"key":"BFbmt2014272_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.leukres.2008.08.022","volume":"33","author":"RJ Chan","year":"2009","unstructured":"Chan RJ, Cooper T, Kratz CP, Weiss B, Loh ML . Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium. Leuk Res 2009; 33: 355\u2013362.","journal-title":"Leuk Res"},{"key":"BFbmt2014272_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1365-2141.2010.08525.x","volume":"152","author":"ML Loh","year":"2011","unstructured":"Loh ML . Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukemia. Br J Haemtol 2011; 152: 677\u2013687.","journal-title":"Br J Haemtol"},{"key":"BFbmt2014272_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fped.2014.00025","volume":"2","author":"CC Dvorak","year":"2014","unstructured":"Dvorak CC, Loh ML . Juvenile myelomonocytic leukemia: molecular pathogenesis informs current approaches to therapy and hematopoietic cell transplantation. Front Pediatr 2014; 2: 1\u20139.","journal-title":"Front Pediatr"},{"key":"BFbmt2014272_CR4","doi-asserted-by":"crossref","unstructured":"Locatelli F, N\u00f6llke P, Zecc M, Korthof E, Lanino E, Peters C et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia: results of the EWOG-MDS\/EBMT trial. Blood 105: 410\u2013419.","DOI":"10.1182\/blood-2004-05-1944"},{"key":"BFbmt2014272_CR5","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.bbmt.2007.03.003","volume":"13","author":"J Russell","year":"2007","unstructured":"Russell J, Savoie ML, Balogh A, Turner AR, Larratt L, Chaudry MA et al. Allogeneic transplantation for adult acute leukemia in first or second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin. Biol Blood Marrow Transplant 2007; 13: 814\u2013821.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014272_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.bbmt.2008.03.009","volume":"14","author":"BS Andersson","year":"2008","unstructured":"Andersson BS, de Lima M, Thall PF, Wang X, Couriel D, Korbling M et al. Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favourably with i.v. busulfan and cyclophosphamide (i.v. Bu-Cy2) as pretransplant conditioning therapy in AML\/MDS. Biol Blood Marrow Transplant 2008; 14: 672\u2013684.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014272_CR7","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/01.cco.0000357469.83960.12","volume":"21","author":"BS Andersson","year":"2009","unstructured":"Andersson BS, de Lima M, Thall PF, Madden T, Russell JA, Champlin RE . Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia. Curr Opin Oncol 2009; 21: S11\u2013S15.","journal-title":"Curr Opin Oncol"},{"key":"BFbmt2014272_CR8","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1182\/blood-2002-06-1860","volume":"101","author":"G McDonald","year":"2003","unstructured":"McDonald G, Slattery J, Bouvier M, Ren S, Batchelder A, Kalhorn T et al. Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. Blood 2003; 101: 2043\u20132048.","journal-title":"Blood"},{"key":"BFbmt2014272_CR9","first-page":"316","volume-title":"Thomas \u2019Hematopoietic Cell Transplantation","author":"WI Bensinger","year":"2008","unstructured":"Bensinger WI . High-dose preparatory regimens. Appelbaum FR, Forman SJ, Negrin RS, Blume KG (eds). Thomas \u2019Hematopoietic Cell Transplantation. 4th edn Wiley-Blackwell: Chichester, West Sussex, UK, 2008, 316\u2013332."},{"key":"BFbmt2014272_CR10","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1399-3046.2008.00931.x","volume":"12","author":"M Yabe","year":"2008","unstructured":"Yabe M, Sako M, Yabe H, Osugi Y, Kurosawa H, Nara T et al. A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia. Pediatr Transplant 2008; 12: 862\u2013867.","journal-title":"Pediatr Transplant"},{"key":"BFbmt2014272_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.bbmt.2009.11.017","volume":"16","author":"JA Russell","year":"2010","unstructured":"Russell JA, Irish W, Balogh A, Chaudry MA, Savoie ML, Turner AR et al. The addition of 400 cGY total body irradiation to a regimen incorporating once-daily intravenous busulfan, fludarabine, and anti-thymocyte globulin reduces relapse without affecting nonrelapse mortality in acute myelogenous leukemia. Biol Blood Marrow Transplant 2010; 16: 509\u2013514.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014272_CR12","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1182\/blood-2004-08-3312","volume":"105","author":"JE Sanders","year":"2005","unstructured":"Sanders JE, Im HJ, Hoffmeister PA, Gooley TA, Woolfrey AE, Carpenter PA et al. Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia. Blood 2005; 105: 3749\u20133756.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2014272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2014272","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2014272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T18:30:32Z","timestamp":1659119432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2014272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,8]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["BFbmt2014272"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2014.272","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,8]]},"assertion":[{"value":"8 December 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}